Related Experiment Video
Updated: Dec 24, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Immunopathogenesis and therapeutic vaccine strategies for chronic hepatitis B virus infection
1Laboratoire de pathogenèse des virus de l'hépatite B, Département de virologie, Institut Pasteur, 28, rue du Dr. Roux, 75724 Paris cedex 15 France, Inserm U845, Institut Pasteur, Centre de recherche « croissance et signalisation », département de virologie, 28, rue du Docteur-Roux, 75724 Paris cedex 15, France.
Abstract:
More than two billions individuals are with serological markers of a recent or past hepatitis B virus (HBV) infection. Vaccination is the most efficient way to prevent new infections and in this matter, vaccines have been available for more than 30 years. Despite this, 370 millions of individuals are chronic carriers of this virus. Current treatments for chronic hepatitis B do not eliminate the virus but improve significantly the disease. Owing to the major limitations of these antiviral therapies, there is a strong need for novel therapeutic approaches to this major health problem. Stimulation of the host's innate and adaptive immunity in a way that results in the resolution of viral infection is a promising approach. A better understanding of the virus-host interaction in acute and chronic HBV infection revealed several possible targets for immunotherapy. In the present review we will discuss the current state of the art in HBV therapeutic vaccines.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...